Publications by authors named "Angela K Ulrich"

In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote development of effective medical countermeasures (ie, diagnostics, therapeutics, and vaccines) against Lassa fever. Diagnostic testing for Lassa fever has important limitations and key advancements are needed to ensure rapid and accurate diagnosis.

View Article and Find Full Text PDF

Nipah virus causes highly lethal disease, with case-fatality rates ranging from 40% to 100% in recognised outbreaks. No treatments or licensed vaccines are currently available for the prevention and control of Nipah virus infection. In 2019, WHO published an advanced draft of a research and development roadmap for accelerating development of medical countermeasures, including diagnostics, therapeutics, and vaccines, to enable effective and timely emergency response to Nipah virus outbreaks.

View Article and Find Full Text PDF

We assessed human immunodeficiency virus (HIV) load in plasma and semen during primary HIV infection using serial samples of semen and plasma during the first 24 weeks after diagnosis in untreated participants and those who started antiretroviral therapy (ART) immediately at diagnosis. In the absence of treatment, semen viral load was >1000 copies/mL in almost all specimens (83%) collected 2-10 weeks after the estimated date of HIV acquisition and remained >1000 copies/mL in 35% of untreated participants at the last observed time point. Thus, in the absence of ART, semen viral load remained at a level consistent with transmissibility throughout primary infection.

View Article and Find Full Text PDF

Statistical analysis to evaluate mechanistic pathways can be limited by non-causal associations as well as co-linearity of high-dimensional data. Here, we present a protocol evaluating statistical associations between multiple exposure variables (sociodemographic and behavioral), immune biomarkers, and HIV acquisition. We describe steps for study setup, combining Least Absolute Shrinkage and Selective Operator with the standard regression approach, and building nested models.

View Article and Find Full Text PDF

Background: Sex and gender are believed to influence vaccine response. Yet, the relationship between sex and gender and COVID-19 vaccine efficacy is poorly understood and remains under-investigated.

Methods: We conducted a systematic review to determine whether and to what extent post-approval COVID-19 vaccine effectiveness (VE) studies report sex-disaggregated VE data.

View Article and Find Full Text PDF

COVID-19 continues to be a public health concern in the United States. Although safe and effective vaccines have been developed, a significant proportion of the US population has not received a COVID-19 vaccine. This cross-sectional study aimed to describe the demographics and behaviors of Minnesota adults who have not received the primary series of the COVID-19 vaccine, or the booster shot using data from the Minnesota COVID-19 Antibody Study (MCAS) collected through a population-based sample between September and December 2021.

View Article and Find Full Text PDF
Article Synopsis
  • Seasonal flu vaccination rates are low in the US, leading to preventable cases, hospitalizations, and deaths, prompting the need to identify effective interventions to boost vaccine willingness among under-vaccinated age groups.
  • The study evaluated various interventions, such as the source and type of vaccination messages, incentives, and ease of access, through hypothetical scenarios involving 1,763 Minnesota residents to determine what influences individuals' willingness to get vaccinated.
  • The findings revealed that easy access to vaccination sites had the most significant impact on encouraging vaccine willingness across all age groups, while small financial incentives were particularly effective for younger individuals.
View Article and Find Full Text PDF
Article Synopsis
  • Broadly protective coronavirus vaccines are essential for fighting off future versions of SARS-CoV-2 and other novel coronaviruses, helping to reduce the impact of potential outbreaks.
  • The Coronavirus Vaccines Research and Development (R&D) Roadmap (CVR) is a structured plan funded by major foundations, created through collaboration among experts, and outlines vital research areas and strategic goals.
  • Organized into five key topics, the CVR includes 20 goals and 86 R&D milestones, with 26 identified as high priority, to help direct funding and research efforts in making effective vaccines.
View Article and Find Full Text PDF

Background: , a treatment-as-prevention intervention among men who have sex with men and transgender women in Lima, Peru, was developed to identify HIV during early primary infection (<3 months from acquisition) through monthly serologic assays and HIV RNA tests. Newly diagnosed individuals were rapidly linked to care and offered to initiate ART. In this study we sought to study the cost-effectiveness of compared to the standard of care (SOC) for HIV testing and initiation of treatment.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how often US college students practiced preventative COVID-19 behaviors and their willingness to get vaccinated during the pandemic.
  • Out of the 653 college students surveyed from March to August 2020, a significant majority (81.5%) expressed willingness to get vaccinated, with preventive behavior engagement being generally high.
  • No major differences were found in preventative behavior or vaccine willingness based on sex or location, with the primary motivation for vaccination being a desire to help end COVID-19 outbreaks.
View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the importance of laboratory biomarkers in managing COVID-19 patients and points out limitations in previous systematic reviews that primarily focused on a narrow range of biomarkers and geographical bias.
  • The objective was to provide a comprehensive analysis of various laboratory biomarkers and their correlation with mortality in hospitalized COVID-19 patients, using data from multiple countries.
  • The review covered 94 case-series studies, revealing notable relationships between certain biomarkers (like troponin and IL-6) and mortality rates, while also indicating significant variations across different countries.
View Article and Find Full Text PDF

Background: The majority of healthcare workers (HCW) in the US report being fully vaccinated against COVID-19, yet little is known about vaccine decision-making for their household members, including children.

Methods: Cross-sectional survey July-August 2021 of HCW and their household members in Minnesota.

Results: 94 % of eligible participants were vaccinated with the most common reasons being wanting to protect oneself, family and loved ones.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to identify factors influencing university students' willingness to receive new vaccines for emerging diseases through a discrete choice experiment conducted at Makerere University in 2019.
  • - Out of 1,576 participants, nearly 78% expressed willingness to get vaccinated, with health professional students showing higher acceptance compared to other disciplines; higher severity and risk of disease, along with recommendations from health officials, increased willingness.
  • - Findings suggest that vaccination campaigns should tailor messaging based on disease severity and trusted health leader endorsements, which can enhance uptake of new vaccines.
View Article and Find Full Text PDF

Background: Monitoring COVID-19 infection risk among health care workers (HCWs) is a public health priority. We examined the seroprevalence of SARS-CoV-2 among HCWs following the fall infection surge in Minnesota, and before and after COVID-19 vaccination. Additionally, we assessed demographic and occupational risk factors for SARS-CoV-2 infection.

View Article and Find Full Text PDF

Most SARS-CoV-2 antibody assays cannot distinguish between antibodies that developed after natural infection and those that developed after vaccination. We assessed the accuracy of a nucleocapsid-containing assay in identifying natural infection among vaccinated individuals. A longitudinal cohort composed of health care workers in the Minneapolis/St.

View Article and Find Full Text PDF
Article Synopsis
  • - The review explores the unclear relationship between the dose of SARS-CoV-2, the resultant infection, and the severity of COVID-19 outcomes, highlighting gaps in current research.
  • - Host factors like age, sex, and pre-existing health conditions significantly affect COVID-19 severity in humans, while animal models often show milder symptoms despite varying doses.
  • - The article calls for improved study designs in both animal and human research to better understand the impact of viral dose on disease severity, as current findings are inconsistent.
View Article and Find Full Text PDF

Objective: We categorized levels of self-reported stress, anxiety, worry, and sleep among US college and university students during the COVID-19 pandemic.

Methods: We conducted an anonymous online survey between May 7 and June 21, 2020.

Results: Nearly all participants reported worry about the pandemic.

View Article and Find Full Text PDF

Importance: Identification of SARS-CoV-2 infection via antibody assays is important for monitoring natural infection rates. Most antibody assays cannot distinguish natural infection from vaccination.

Objective: To assess the accuracy of a nucleocapsid-containing assay in identifying natural infection among vaccinated individuals.

View Article and Find Full Text PDF

Transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is possible among symptom-free individuals. Patients are avoiding medically necessary healthcare visits for fear of becoming infected in the healthcare setting. We screened 489 symptom-free healthcare workers for SARS-CoV-2 and found no positive results, strongly suggesting that the prevalence of SARS-CoV-2 was <1%.

View Article and Find Full Text PDF

It is unclear how broadly aware parents are of the concept of herd immunity and whether parents consider community benefits of vaccination when making decisions about their child's vaccinations. We aimed to determine whether educating parents about community-level benefits of measles, mumps, and rubella (MMR) vaccination and local vaccination rates would impact concern about their child's risk of measles and risk of a measles outbreak. We conducted an electronic survey among Minnesota parents of children aged 6-18 years in August 2016.

View Article and Find Full Text PDF

Background: Little is known about adherence to American Heart Association/American Stroke Association (AHA/ASA) stroke performance measures in developing countries like Peru.

Aims: We assessed adherence and determined factors associated with adherence to the AHA/ASA stroke performance measures at a reference center for neurological diseases in Lima, Peru.

Methods: We conducted a retrospective chart review of 150 stroke patients admitted to the Neurological Institute of Neurological Science from 2014 to 2016 to ascertain adherence to 15 different AHA/ASA stroke performance measures.

View Article and Find Full Text PDF

Background: Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is possible among symptom-free individuals and some patients are avoiding medically necessary healthcare visits for fear of becoming infected in the healthcare setting. Limited data are available on the point prevalence of SARS-CoV-2 infection in symptom-free U.S.

View Article and Find Full Text PDF